Irvine, California-based Masimo designed its W1 watch to offer accurate, continuous measurements and insightful health data. The wrist-worn wearable builds on the company’s personal, lifestyle-friendly designs for non-invasive blood parameter monitoring.
For the first time in a watch format, the company said, W1 provides accurate, continuous monitoring of oxygen saturation (SpO2). It also provides pulse rate, respiration rate and more measurements. In a limited market release, the Masimo W1 offers hydration index measurements.
The device takes 86,400 measurements a day for second-by-second data trending. It pairs through secure Bluetooth to the Masimo Health smartphone app.
Masimo launched the Personal SafetyNet alongside the watch. Personal SafetyNet, a paid subscription service within the company’s app, gives users access to reporting tools to help them review their physiological status over time. It also facilitates sharing data and virtual visits with doctors.
“Masimo W1 is a gamechanger,” Olympic silver medalist Morgan Pearson said in a news release. “As a professional triathlete, I’m always looking to optimize my performance in every way possible. With Masimo W1 I can continuously monitor lots of vital signs, even my level of hydration. This essential continuous data will help me track and improve my physiological performance in the most demanding of race conditions.”
Use in medical applications?
Masimo W1 is pending FDA clearance for use in medical applications.
The company is entering the general launch phase of a medical version of W1 for use in medical applications outside the U.S. That features additional capabilities such as ECG, AFib detection and more. The medical version will also be available for use in telehealth and telemonitoring with SafetyNet.
The W1 watch is approved for use in medical applications in Saudi Arabia. Dr. Bakhsh, head of heart function at Prince Sultan Cardiac Center, said the hospital has already begun using the watch. In remote monitoring for chronic heart failure patients, it proved comfortable to wear with continuous measurements providing the staff confidence in keeping patients safe.
“With over 30 years of experience in medical monitoring and telemedicine, we are excited to bring the first wearable device to offer accurate and continuous pulse oximetry, hydration index, and other health measurements to consumers,” Masimo founder and CEO Joe Kiani said. “The SET technology we invented for hospitals transformed patient monitoring, saved lives, and reduced the cost of care. Based on the feedback we have received from those who have tested Masimo W1 during the limited market release phase, we believe this watch will improve lives.”
